Leonid Timashev
Stock Analyst at RBC Capital
(4.82)
# 522
Out of 4,421 analysts
440
Total ratings
56.9%
Success rate
20.5%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Initiated Coverage: Buy | $449 | $282.31 | +59.05% | 1 | Jun 17, 2026 | |
| EWTX Edgewise Therapeutics | Rated: Buy | $48 → $59 | $36.81 | +60.28% | 39 | Jun 17, 2026 | |
| ALKS Alkermes | Maintained: Buy | $45 → $56 | $44.99 | +24.47% | 20 | Jun 8, 2026 | |
| INSM Insmed | Maintained: Buy | $195 | $95.80 | +103.55% | 22 | Jun 5, 2026 | |
| ADCT ADC Therapeutics | Downgraded: Hold | $6 → $2 | $1.09 | +83.49% | 15 | Jun 3, 2026 | |
| ONC BeOne Medicines AG | Rated: Buy | $425 → $436 | $270.15 | +61.39% | 14 | Jun 2, 2026 | |
| RVMD Revolution Medicines | Rated: Buy | $165 → $182 | $162.99 | +11.66% | 10 | Jun 2, 2026 | |
| LEGN Legend Biotech | Maintained: Buy | $64 | $27.93 | +129.14% | 43 | Jun 1, 2026 | |
| BHVN Biohaven | Maintained: Buy | $22 | $13.57 | +62.12% | 29 | May 28, 2026 | |
| DSGN Design Therapeutics | Maintained: Buy | $14 → $20 | $12.44 | +60.77% | 24 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 | $8.67 | +61.48% | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $0.453 | +562.25% | 7 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.03 | +146.31% | 16 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $22 | $12.53 | +75.58% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.95 | +374.58% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $79 → $81 | $61.08 | +32.61% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $4.12 | +264.08% | 12 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 | $51.91 | -17.16% | 15 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $195 → $258 | $224.66 | +14.84% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 | $29.83 | +57.56% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 → $119 | $78.78 | +51.05% | 21 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $12.64 | +50.32% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $242 → $302 | $250.50 | +20.56% | 37 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $31.23 | +69.71% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $5.56 | +259.71% | 10 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $4.00 | +25.00% | 4 | Apr 30, 2026 |
Praxis Precision Medicines
Jun 17, 2026
Initiated Coverage: Buy
Price Target: $449
Current: $282.31
Upside: +59.05%
Edgewise Therapeutics
Jun 17, 2026
Rated: Buy
Price Target: $48 → $59
Current: $36.81
Upside: +60.28%
Alkermes
Jun 8, 2026
Maintained: Buy
Price Target: $45 → $56
Current: $44.99
Upside: +24.47%
Insmed
Jun 5, 2026
Maintained: Buy
Price Target: $195
Current: $95.80
Upside: +103.55%
ADC Therapeutics
Jun 3, 2026
Downgraded: Hold
Price Target: $6 → $2
Current: $1.09
Upside: +83.49%
BeOne Medicines AG
Jun 2, 2026
Rated: Buy
Price Target: $425 → $436
Current: $270.15
Upside: +61.39%
Revolution Medicines
Jun 2, 2026
Rated: Buy
Price Target: $165 → $182
Current: $162.99
Upside: +11.66%
Legend Biotech
Jun 1, 2026
Maintained: Buy
Price Target: $64
Current: $27.93
Upside: +129.14%
Biohaven
May 28, 2026
Maintained: Buy
Price Target: $22
Current: $13.57
Upside: +62.12%
Design Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $14 → $20
Current: $12.44
Upside: +60.77%
May 14, 2026
Rated: Buy
Price Target: $14
Current: $8.67
Upside: +61.48%
May 14, 2026
Maintained: Hold
Price Target: $4 → $3
Current: $0.453
Upside: +562.25%
May 14, 2026
Maintained: Buy
Price Target: $5
Current: $2.03
Upside: +146.31%
May 13, 2026
Maintained: Buy
Price Target: $21 → $22
Current: $12.53
Upside: +75.58%
May 11, 2026
Maintained: Buy
Price Target: $14
Current: $2.95
Upside: +374.58%
May 8, 2026
Rated: Buy
Price Target: $79 → $81
Current: $61.08
Upside: +32.61%
May 7, 2026
Maintained: Buy
Price Target: $15
Current: $4.12
Upside: +264.08%
May 6, 2026
Maintained: Hold
Price Target: $43
Current: $51.91
Upside: -17.16%
May 6, 2026
Rated: Buy
Price Target: $195 → $258
Current: $224.66
Upside: +14.84%
May 6, 2026
Maintained: Buy
Price Target: $47
Current: $29.83
Upside: +57.56%
May 5, 2026
Maintained: Buy
Price Target: $101 → $119
Current: $78.78
Upside: +51.05%
May 5, 2026
Maintained: Buy
Price Target: $19
Current: $12.64
Upside: +50.32%
May 5, 2026
Maintained: Buy
Price Target: $242 → $302
Current: $250.50
Upside: +20.56%
May 5, 2026
Maintained: Buy
Price Target: $53
Current: $31.23
Upside: +69.71%
May 4, 2026
Maintained: Buy
Price Target: $20
Current: $5.56
Upside: +259.71%
Apr 30, 2026
Maintained: Hold
Price Target: $7 → $5
Current: $4.00
Upside: +25.00%